Hippo signaling inhibition in AD mice
收藏官方服务：
资源简介：
Western blot images
应用场景：
创建时间：
2025-02-01
相关数据集
Gender differences contribute to variability of serum lipid biomarkers for Alzheimer’s disease - Supplemental Table 4
Background: Alzheimer’s disease (AD) cannot currently be diagnosed by a blood test. One reason may be gender differences. Another may be the statistical methods used. The authors evaluate these possib
DataCite Commons2024-05-17 更新140
Gene expression changes caused by YAP overexpression and Nf2 deletion in the developing mouse brain
The transcriptional coactivator YAP is the key downstream effector of the Hippo pathway. YAP overexpression in the developing mouse brain results in excessive expansion of the neural progenitor pool a
NIAID Data Ecosystem70
Global microRNA expression analysis in HaCaT human keratinocytes transfected with siRNA(s) for p72, NF2/LATS2, DROSHA/DGCR8, or negative control. Homo sapiens
Global downregulation of microRNAs (miRNAs) is commonly observed in human cancers and can have a causative role in tumorigenesis. The mechanisms responsible for this phenomenon remain poorly understoo
NIAID Data Ecosystem50
Candidate CSF biomarkers reflect AD-related pathophysiologic changes.
CSF biomarkers are grouped according to reported function(s) and, when appropriate, cellular locations. Asterisks (*) indicate those biomarkers found to be increased in AD CSF; the vast majority were
NIAID Data Ecosystem110
Sundown syndrome in patients with Alzheimer’s disease dementia
ABSTRACT The sundown syndrome is a complex neurobehavioral disorder in patients with dementia associated with high financial cost and significant caregiver burden. It is a multifactorial phenomenon wi
DataCite Commons2021-03-25 更新70
